• AAPL 193.42
  • TSLA 238.72
  • AMZN 146.88
  • BTC-USD 44006.1523
  • ETH-USD 2293.7131
  • EURUSD 1.0794
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. ADMP.US

Adamis Pharma (ADMP NASDAQ) stock market data APIs

$0.5 0.01(2%) as of November 9, 2023

Adamis Pharma Financial Data Overview

0.4901
0.5
-
0.5175
0.49
0.4505-21.7
7 253 K
9 359 K
5 022 K
0
1.2777
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ADMP',
Type: 'Common Stock',
Name: 'Adamis Pharma',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: NULL,
ISIN: NULL,
CUSIP: NULL,
CIK: '887247',
EmployerIdNumber: '82-0429727',
FiscalYearEnd: 'December',
IPODate: '1995-08-14',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
GicSector: 'Health Care',
GicGroup: 'Pharmaceuticals, Biotechnology & Life Sciences',
GicIndustry: 'Pharmaceuticals',
GicSubIndustry: 'Pharmaceuticals',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Adamis Pharma Fundamental Data is available in our Financial Data APIs

  • Net Revenue 5 022 K
  • EBITDA -17 794 120
  • Earnings Per Share -10.14
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $49.99 See full price
Get sample
of Fundamental API Data

Get Adamis Pharma Earnings via APIs

  • Latest Release 2023-11-13
  • EPS/Forecast NaN

Get Adamis Pharma End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Adamis Pharma latest news via APIs

Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus

SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the company changed its name to DMK Pha...
  • ADAMIS PHARMACEUTICALS CORPORATION
  • NASDAQ:ADMP
  • PRODUCT / SERVICES ANNOUNCEMENT

Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) --  Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced financial results for the second quart...
  • ADAMIS PHARMACEUTICALS CORPORATION
  • EARNINGS RELEASES AND OPERATING RESULTS
  • NASDAQ:ADMP
Still have any questions?

Or need any other data for equities, funds or ETFs? Send us an email.

support@eodhistoricaldata.com